48824EGP
- Active ingredient
- vedolizumab
- Strength
- 300 mg
- Form
- vial
- Manufacturer
- takeda > pharma overseas
- Route
- injection
Uses
Used for moderate to severe ulcerative colitis and Crohn's disease.
Do not use if
Contraindicated in severe hypersensitivity to vedolizumab.
Side effects
Headache, nausea, fatigue, arthralgia, and infections may occur.
Warnings
Monitor for infections and infusion-related reactions.
How it works
A monoclonal antibody that blocks lymphocyte migration into gastrointestinal tissue.
Storage
Store refrigerated at 2–8°C.